Detection of anti-heparin-PF4 complex antibodies in COVID-19 patients on heparin therapy.
作者信息
Dragonetti Daniela, Guarini Giuseppe, Pizzuti Michele
机构信息
Department of Clinical Laboratory, "San Carlo" Regional Hospital, Potenza, Italy.
COVID Intensive Care, "San Carlo" Regional Hospital, Potenza, Italy.
出版信息
Blood Transfus. 2020 Jul;18(4):328. doi: 10.2450/2020.0164-20.
Abstract
摘要
相似文献
1
Detection of anti-heparin-PF4 complex antibodies in COVID-19 patients on heparin therapy.
Blood Transfus. 2020 Jul;18(4):328. doi: 10.2450/2020.0164-20.
2
Incidence of heparin-induced thrombocytopenia in patients with 2019 coronavirus disease.
Med Clin (Barc). 2020 Nov 13;155(9):409-410. doi: 10.1016/j.medcli.2020.05.041. Epub 2020 Jul 28.
3
Coronavirus Disease 2019, Prothrombotic Factors, and Venous Thromboembolism.
Semin Thromb Hemost. 2020 Oct;46(7):772-776. doi: 10.1055/s-0040-1710337. Epub 2020 May 11.
4
Coagulation abnormalities and thrombosis in patients with COVID-19.
Lancet Haematol. 2020 Jun;7(6):e438-e440. doi: 10.1016/S2352-3026(20)30145-9. Epub 2020 May 11.
5
Coagulation changes and thromboembolic risk in COVID-19 obstetric patients.
Anaesth Crit Care Pain Med. 2020 Jun;39(3):351-353. doi: 10.1016/j.accpm.2020.05.003. Epub 2020 May 11.
6
COVID-19 patient with immune thrombocytopenic purpura.
Int J Lab Hematol. 2020 Dec;42(6):e260-e262. doi: 10.1111/ijlh.13303. Epub 2020 Aug 12.
7
Venous thromboembolism in non-critically ill patients with COVID-19 infection.
Thromb Res. 2020 Sep;193:166-169. doi: 10.1016/j.thromres.2020.07.033. Epub 2020 Jul 17.
8
Plasmacytoid lymphocytes in SARS-CoV-2 infection (Covid-19).
Am J Hematol. 2020 Jul;95(7):861-862. doi: 10.1002/ajh.25834. Epub 2020 Apr 28.
9
Autoimmune heparin-induced thrombocytopenia.
J Thromb Haemost. 2017 Nov;15(11):2099-2114. doi: 10.1111/jth.13813. Epub 2017 Sep 28.
10
Heparin-induced thrombocytopenia (HIT II) - a drug-associated autoimmune disease.
Thromb Haemost. 2009 Nov;102(5):887-91. doi: 10.1160/TH09-03-0209.
引用本文的文献
1
The Binding of the SARS-CoV-2 Spike Protein to Platelet Factor 4: A Proposed Mechanism for the Generation of Pathogenic Antibodies.
Biomolecules. 2024 Feb 20;14(3):245. doi: 10.3390/biom14030245.
2
Prevalence and clinical implication of thrombocytopenia and heparin-induced thrombocytopenia in patients who are critically ill with COVID-19.
Clin Med (Lond). 2022 Sep;22(5):403-408. doi: 10.7861/clinmed.2022-0054.
3
High-frequency Contactless Sensor for the Detection of Heparin-Induced Thrombocytopenia Antibodies via Platelet Aggregation.
Int J Mol Sci. 2022 Nov 19;23(22):14395. doi: 10.3390/ijms232214395.
4
Complementary Sets of Autoantibodies Induced by SARS-CoV-2, Adenovirus and Bacterial Antigens Cross-React with Human Blood Protein Antigens in COVID-19 Coagulopathies.
Int J Mol Sci. 2022 Sep 29;23(19):11500. doi: 10.3390/ijms231911500.
5
Molecular mimicry, hyperactive immune system, and SARS-COV-2 are three prerequisites of the autoimmune disease triangle following COVID-19 infection.
Int Immunopharmacol. 2022 Nov;112:109183. doi: 10.1016/j.intimp.2022.109183. Epub 2022 Aug 22.
6
Anticoagulation Strategies in Critically Ill Patients With SARS-CoV-2 Infection: The Role of Direct Thrombin Inhibitors.
J Cardiothorac Vasc Anesth. 2022 Aug;36(8 Pt B):2961-2967. doi: 10.1053/j.jvca.2022.03.004. Epub 2022 Mar 8.
7
An Autoantigen Atlas From Human Lung HFL1 Cells Offers Clues to Neurological and Diverse Autoimmune Manifestations of COVID-19.
Front Immunol. 2022 Mar 24;13:831849. doi: 10.3389/fimmu.2022.831849. eCollection 2022.
8
COVID-19 coagulopathies: Human blood proteins mimic SARS-CoV-2 virus, vaccine proteins and bacterial co-infections inducing autoimmunity: Combinations of bacteria and SARS-CoV-2 synergize to induce autoantibodies targeting cardiolipin, cardiolipin-binding proteins, platelet factor 4, prothrombin, and coagulation factors.
Bioessays. 2021 Dec;43(12):e2100158. doi: 10.1002/bies.202100158. Epub 2021 Oct 22.
9
Label-Free Detection and Characterization of Heparin-Induced Thrombocytopenia (HIT)-like Antibodies.
ACS Omega. 2021 Sep 29;6(40):25926-25939. doi: 10.1021/acsomega.1c02496. eCollection 2021 Oct 12.
10
Effect of HIT Components on the Development of Breast Cancer Cells.
Life (Basel). 2021 Aug 13;11(8):832. doi: 10.3390/life11080832.
本文引用的文献
1
Pulmonary Embolism or Pulmonary Thrombosis in COVID-19? Is the Recommendation to Use High-Dose Heparin for Thromboprophylaxis Justified?
Thromb Haemost. 2020 Aug;120(8):1230-1232. doi: 10.1055/s-0040-1712097. Epub 2020 Apr 29.
2
SARS-CoV-2: a storm is raging.
J Clin Invest. 2020 May 1;130(5):2202-2205. doi: 10.1172/JCI137647.
3
Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis.
Clin Chim Acta. 2020 Jul;506:145-148. doi: 10.1016/j.cca.2020.03.022. Epub 2020 Mar 13.
Zotero 插件